arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Align Technology, Inc.

ALGN Health Care Industrial Specialties
$158.67
▲ +0.0% Today
as of Sep 4, 16:45 ET
Last 30 days -9.66% Jul 28 → Sep 04
$152.85 $160.49 $168.14 $175.78 $183.42 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$157.67
High
$160.49
Low
$155.24
Volume
$990,515
Avg Vol
$1M
Mkt Cap
$12.0B
P/E (TTM)
41.10
Beta
—
52w High
$200.44
52w Low
$122.00
Div Yield
—
Shares Out
$71M

Recent Press Releases & News last 60 days · 25 items

Sep 3 · 23:19 StockStory
Q2 Earnings Outperformers: Align Technology (NASDAQ:ALGN) And The Rest Of The Dental Equipment & Technology Stocks
Aug 31 · 20:08 PR Business Wire
Quentin Blackford to Join Align Technology Board of Directors
Aug 28 · 15:30 Zacks
Why Is Align Technology (ALGN) Down 8.4% Since Last Earnings Report?
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$122
$200
47% of range
Avg surprise (last 2)
-6.3%
Avg reaction (last 1)
-2.5%
0% positive
Latest IV / EM
41%
EM ±1.7% · $160 · Sep 4

Earnings trends

EPS — actual vs estimate Actual Estimate
$0.78$1.11$1.44$1.78$2.11 Actual $1.14Actual $1.46Actual $1.58Actual $1.39Actual $1.28Actual $1.55Actual $1.52Est $1.51Actual $1.83Est $2.11Actual $0.78Actual $1.57Actual $1.51 MarJunSepMarJunSepMar/2025Jun/2025SepMarJun
Revenue vs Net Income Revenue Net income
$0$277M$555M$832M$1.1B Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $1.51 — — — — financials
Tue Mar 31, 2026Mar 2026 $1.57 — — — — financials
Tue Sep 30, 2025Sep 2025 $0.78 — — — — financials
Wed Jul 30, 2025Jun/2025 $1.83 $2.11 -13.3% — — earnings
Wed Apr 30, 2025Mar/2025 $1.52 $1.51 +0.7% — -2.5% earnings
Mon Sep 30, 2024Sep 2024 $1.55 — — — — financials
Sun Jun 30, 2024Jun 2024 $1.28 — — — — financials
Sun Mar 31, 2024Mar 2024 $1.39 — — — — financials
Sat Sep 30, 2023Sep 2023 $1.58 — — — — financials
Fri Jun 30, 2023Jun 2023 $1.46 — — — — financials
Fri Mar 31, 2023Mar 2023 $1.14 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$1.06B$1.04B—$996M$1.01B$979M—$978M
Cost of revenue$299M$304M—$356M$304M$299M—$296M
Gross profit$757M$737M—$639M$708M$680M—$682M
Operating income$154M$142M—$96M$163M$131M—$162M
Net income$108M$113M—$57M$125M$93M—$116M
EPS (diluted)$1.51$1.57—$0.78$1.72$1.27—$1.55

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$1.10B$1.06B$1.09B$1.00B$901M$873M$1.04B$1.04B
Inventory$212M$215M$226M$228M$244M$247M$254M$254M
Total current assets$2.66B$2.66B$2.62B$2.53B$2.45B$2.40B$2.49B$2.60B
Total assets$6.42B$6.31B$6.23B$6.23B$6.22B$6.10B$6.21B$6.37B
Long-term debt————————
Total liabilities$2.19B$2.16B$2.18B$2.28B$2.31B$2.31B$2.36B$2.42B
Total equity$4.23B$4.15B$4.05B$3.96B$3.91B$3.79B$3.85B$3.94B

Implied volatility — last 90 days

37%89%141%193%245% Jun 07 — IV 56% · EM ±5.3%Jun 08 — IV 53% · EM ±4.4%Jun 09 — IV 53% · EM ±3.8%Jun 10 — IV 63% · EM ±3.7%Jun 11 — IV 102% · EM ±4.2%Jun 15 — IV 53% · EM ±3.9%Jun 16 — IV 52% · EM ±3.1%Jun 17 — IV 87% · EM ±3.6%Jun 19 — IV 42% · EM ±4.6%Jun 22 — IV 60% · EM ±5.0%Jun 23 — IV 54% · EM ±3.9%Jun 24 — IV 54% · EM ±3.2%Jun 25 — IV 61% · EM ±2.6%Jun 29 — IV 57% · EM ±13.5%Jun 30 — IV 55% · EM ±12.8%Jul 01 — IV 58% · EM ±13.2%Jul 02 — IV 58% · EM ±13.1%Jul 03 — IV 59% · EM ±13.1%Jul 06 — IV 61% · EM ±12.7%Jul 07 — IV 62% · EM ±12.7%Jul 08 — IV 62% · EM ±12.4%Jul 09 — IV 66% · EM ±13.0%Jul 10 — IV 62% · EM ±11.9%Jul 13 — IV 66% · EM ±11.6%Jul 14 — IV 67% · EM ±11.6%Jul 15 — IV 70% · EM ±11.8%Jul 16 — IV 68% · EM ±11.1%Jul 17 — IV 70% · EM ±11.0%Jul 20 — IV 79% · EM ±10.9%Jul 21 — IV 80% · EM ±10.5%Jul 22 — IV 84% · EM ±10.5%Jul 23 — IV 87% · EM ±10.3%Jul 24 — IV 92% · EM ±10.1%Jul 27 — IV 134% · EM ±11.2%Jul 28 — IV 154% · EM ±11.2%Jul 29 — IV 245% · EM ±14.5%Jul 30 — IV 81% · EM ±3.4%Aug 03 — IV 48% · EM ±4.0%Aug 04 — IV 38% · EM ±2.7%Aug 05 — IV 63% · EM ±3.7%Aug 06 — IV 45% · EM ±1.9%Aug 10 — IV 53% · EM ±4.4%Aug 11 — IV 41% · EM ±3.0%Aug 12 — IV 41% · EM ±2.4%Aug 13 — IV 51% · EM ±2.1%Aug 17 — IV 60% · EM ±5.0%Aug 18 — IV 42% · EM ±3.1%Aug 19 — IV 46% · EM ±2.7%Aug 20 — IV 40% · EM ±1.7%Aug 24 — IV 59% · EM ±4.9%Aug 25 — IV 57% · EM ±4.1%Aug 26 — IV 55% · EM ±3.2%Aug 27 — IV 81% · EM ±3.4%Aug 31 — IV 53% · EM ±4.4%Sep 01 — IV 60% · EM ±4.4%Sep 02 — IV 103% · EM ±6.1%Sep 03 — IV 41% · EM ±1.7%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in